Estrogen replacement therapy and the development of osteoarthritis

Epidemiology

Volumn 7, Issue 4, 1996, Pages 415-419

  Oliveria, Susan A ^a,f   Felson, David T ^b,c   Klein, Raymond A ^d   Reed, John I ^e   Walker, Alexander M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d WYETH AYERST RESEARCH   (United States)

^e Fallon Clinic   (United States)

^f STRANG CANCER PREVENTION CENTER   (United States)

Author keywords

estrogen replacement therapy; health care utilization; health maintenance organization; hormone replacement therapy; nested case control study; osteoarthritis; women

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; NORMAL HUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UTILIZATION REVIEW;

EID: 0029941407     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199607000-00013     Document Type: Article

References (42)

1. Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 1988;10:1-28.
2. Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly: the Framingham Osteoarthritis Study. Arthritis Rheum 1987;30:914-918.
3. Bergström G, Aniansson A, Bjelle A, Grimby G, Lundgren-Lindquist B, Svanborg A. Functional consequences of joint impairment at age 79. Scand J Rehabil Med 1985;17:183-190.
4. Yelin E, Lubeck D, Holman H, Epstein W. The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthritis compared to controls. J Rheumatol 1987;14:710-717.
5. Badley EM, Tennant A. Impact of disablement due to rheumatic disorders in a British population: estimates of severity and prevalence from the Calderdale Rheumatic Disablement Survey. Ann Rheum Dis 1993;52:6-13.
6. Kramer JS, Yelin EH, Epstein WV. Social and economic impacts of four musculoskeletal conditions: a study using national community-based data. Arthritis Rheum 1983;26:901-906.
7. Felts W, Yelin E. The economic impact of the rheumatic diseases in the United States. J Rheumatol 1989;16:867-884.
8. Felson DT. Osteoarthritis. Rheum Dis Clin North Am 1990;16:499-512.
9. National Center for Health Statistics. Basic Data on Arthritis of the Knee, Hip, and Sacroiliac Joints, in Adults Ages 25-74 years, United States, 1971-1975 (Vital and Health Statistics, Series 11, No. 213). DHEW Pub. No. (PHS)79-1661. Rockville, MD: National Center for Health Statistics, 1979.
10. Oliveria SA, Felson DT, Reed JI, Cirillo P, Walker AM. Incidence of symptomatic hand, hip and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 1995;38:1134-1141.
11. Hannan MT, Felson DT, Anderson JJ, Naimark A, Kannel WB. Estrogen use and radiographic osteoarthritis of the knee in women: the Framingham Osteoarthritis Study. Arthritis Rheum 1990;33:525-532.
12. Samanta A, Jones A, Regan M, Wilson S, Doherty M. Is osteoarthritis in woman affected by hormonal changes or smoking? Br J Rheumatol 1993;32:366-370.
13. Nevitt MC, Cummings SR, Lane NE, Genant HK, Pressman AR. Current use of oral estrogen is associated with a decreased prevalence of radiographic hip OA in elderly white women (Abstract). Arthritis Rheum 1994;37(suppl)315:S212.
14. Cauky JA, Kwoh CK, Egeland G, Nevitt MC, Cooperstein L, Rohay J, Towers A, Gutai JP. Serum sex hormones and severity of osteoarthritis of the hand. J Rheumatol 1993;20:1170-1175.
15. Tsai CL, Liu TK, Chen TJ. Estrogen and osteoarthritis: a study of synovial estradiol and estradiol receptor binding in human osteoarthritic knees. Biochem Biophys Res Commun 1992;183:1287-1291.
16. Spector TD, Perry LA, Jubb RW. Endogenous sex steroid levels in women with generalised osteoarthritis. Clin Rheumatol 1991;10:316-319.
17. Kellgren JH, Lawrence JS. Atlas of Standard Radiographs: the Epidemiology of Chronic Rheumatism. Oxford: Blackwell Scientific Publications, 1963.
18. Walker AM. Efficient assessment of confounder effects in matched follow-up studies. J R Stat Soc (Series C) 1982;1:293-297.
19. Rothman KH. Modern Epidemiology. Boston: Little, Brown, 1986.
20. Rosner IA, Malemud CJ, Goldberg VM, Papay RS, Getzy L, Moskowitz RW. Pathologic and metabolic responses of experimental osteoarthritis to estradiol and an estradiol antagonist. Clin Orthop 1982;171:280-286.
21. Rosner IA, Goldberg VM, Getzy L, Moskowitz RW. Effects of estrogen on cartilage and experimentally induced osteoarthritis. Arthritis Rheum 1979;22:52-58.
22. Silberberg M, Silberberg R. Modifying action of estrogen on the evolution of osteoarthrosis in mice of different ages. Endocrinology 1963;72:449-451.
23. Silberberg M, Silberberg R. Age-linked modification of the effect of estrogen on joints and cortical bone of female mice. Gerontologia 1970;16:201-211.
24. Rosner IA, Goldberg VM, Moskowitz RW. Estrogens and osteoarthritis. Clin Orthop 1986;213:77-83.
25. Tsai C, Liu T. Osteoarthritis in women: its relationship to estrogens and current trends. Life Sci 1992;50:1737-1744.
26. Rosner IA, Malemud CJ, Hassid AI, Goldberg VM, Boja BA, Moskowitz RW. Estradiol and tamoxifen stimulation of lapine articular chondrocyte prostaglandin synthesis. Prostaglandins 1983;26:123-139.
27. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clark AC. Long-term prevention of postmenopausal osteoporosis by estrogen: evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976;1:1038-1041.
28. Horsman A, Jones M, Francis R, Nordin B. The effect of estrogen dose on postmenopausal bone loss. N Engl J Med 1983;309:1404-1407.
29. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy. I. A 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 1979;53:277-281.
30. Recker RR, Saville PD, Heany RP. Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med 1977;87:649-655.
31. Radin EL, Paul IL, Rose RM. Role of mechanical factors in pathogenesis of primary osteoarthritis. Lancet 1972;2:519-522.
32. Milgram JW. Osteopetrosis: a morphological study of twenty-one cases. J Bone Joint Surg Am 1982;64A:912-929.
33. Foss MVL, Byers PD. Bone density, osteoarthrosis of the hip, and fracture of the upper end of the femur. Arm Rheum Dis 1972;31:259-264.
34. Roh YS, Dequeker J, Mulier JC. Bone mass in osteoarthrosis, measured in vivo by photon absorption. J Bone Joint Surg Am 1974;56A:587-591.
35. Dequeker J, Goris P, Uytterhoeven R. Osteoporosis and osteoarthritis (osteoarthrosis): anthropometric distinctions. JAMA 1983;249:1448-1451.
36. Pogrund H, Rutenberg M, Makin M, Robin G, Menczel J, Steinberg R. Osteoarthritis of the hip joint and osteoporosis: a radiological study in a random population sample in Jerusalem. Clin Orthop 1982;164:130-135.
37. Strom BL, Carson JL. Use of automated databases for pharmacoepidemiology research. Epidemiol Rev 1990;12:87-107.
38. Faich GA, Stadel BV. The future of automated record linkage for postmarketing surveillance: a response to Shapiro. Clin Pharmacol Ther 1989;46:387-389.
39. Jick H, Walker AM. Uninformed criticism of automated record linkage (Letter). Clin Pharmacol Ther 1989;46:478-479.
40. Nordstrom DL, Remington PL, Layde PM. The utility of HMO data for the surveillance of chronic diseases. Am J Public Health 1994;84:995-997.
41. Shapiro S. The role of automated record linkage in the postmarketing surveillance of drug safety: a critique. Clin Pharmacol Ther 1989;46:371-386.
42. Gabriel SE. The sensitivity and specificity of computerized databases for the diagnosis of rheumatoid arthritis. Arthritis Rheum 1994;37:821-823.